Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
97864999 | 9786499 | 9 | F | 20070605 | 20160726 | 20131227 | 20160729 | EXP | US-009507513-1312USA009131 | MERCK | 0.00 | F | Y | 70.75000 | KG | 20160729 | LW | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
97864999 | 9786499 | 1 | PS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | 15540.48 | MG | 20560 | 70 | MG | TABLET | /wk | ||||
97864999 | 9786499 | 2 | SS | FOSAMAX PLUS D | ALENDRONATE SODIUMCHOLECALCIFEROL | 1 | Oral | 70 MG/2800 MG, QW | 70 | MG | 0 | 70 | MG | TABLET | /wk | ||||
97864999 | 9786499 | 3 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | 3150 | MG | U | 0 | 70 | MG | /wk | ||||
97864999 | 9786499 | 4 | SS | ZOMETA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 4 MG, ONCE A YEAR | U | 0 | 4 | MG | /yr | ||||||
97864999 | 9786499 | 5 | C | VITAMINS (UNSPECIFIED) | VITAMINS | 1 | Unknown | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
97864999 | 9786499 | 6 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | Unknown | 5000 IU, QD | U | 0 | 5000 | IU | QD | ||||||
97864999 | 9786499 | 7 | C | IRON (UNSPECIFIED) | IRON | 1 | Unknown | 55 MG, QD | U | 0 | 55 | MG | QD | ||||||
97864999 | 9786499 | 8 | C | ASCORBIC ACID. | ASCORBIC ACID | 1 | Unknown | 500 MG, QD | U | 0 | 500 | MG | QD | ||||||
97864999 | 9786499 | 9 | C | XANTHOPHYLL | 2 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD | |||||||
97864999 | 9786499 | 10 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 31 MG, QD | U | 0 | 31 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
97864999 | 9786499 | 1 | Osteoporosis |
97864999 | 9786499 | 3 | Osteoporosis |
97864999 | 9786499 | 4 | Osteoporosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
97864999 | 9786499 | OT |
97864999 | 9786499 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
97864999 | 9786499 | Anaemia postoperative | |
97864999 | 9786499 | Aortic valve sclerosis | |
97864999 | 9786499 | Arteriosclerosis coronary artery | |
97864999 | 9786499 | Breast cancer female | |
97864999 | 9786499 | Cataract | |
97864999 | 9786499 | Chronic obstructive pulmonary disease | |
97864999 | 9786499 | Clavicle fracture | |
97864999 | 9786499 | Constipation | |
97864999 | 9786499 | Fall | |
97864999 | 9786499 | Femur fracture | |
97864999 | 9786499 | Hyperlipidaemia | |
97864999 | 9786499 | Hypothyroidism | |
97864999 | 9786499 | Metastases to bone | |
97864999 | 9786499 | Nasopharyngitis | |
97864999 | 9786499 | Osteoarthritis | |
97864999 | 9786499 | Osteoporosis | |
97864999 | 9786499 | Rib fracture | |
97864999 | 9786499 | Stress cardiomyopathy | |
97864999 | 9786499 | Upper limb fracture | |
97864999 | 9786499 | Urge incontinence |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
97864999 | 9786499 | 1 | 20070316 | 20070416 | 0 | |
97864999 | 9786499 | 2 | 20081031 | 0 | ||
97864999 | 9786499 | 3 | 20080527 | 20090330 | 0 | |
97864999 | 9786499 | 4 | 2009 | 2011 | 0 | |
97864999 | 9786499 | 5 | 2004 | 0 | ||
97864999 | 9786499 | 6 | 1994 | 0 | ||
97864999 | 9786499 | 7 | 2004 | 0 | ||
97864999 | 9786499 | 8 | 2004 | 0 | ||
97864999 | 9786499 | 9 | 2004 | 0 | ||
97864999 | 9786499 | 10 | 1993 | 0 |